Phenotypic Characterization of Circulating CD4+ T Cells in ANCA-Associated Vasculitis

被引:13
作者
Lilliebladh, Sandra [1 ]
Johansson, Asa [2 ]
Pettersson, Asa [1 ]
Ohlsson, Sophie [1 ]
Hellmark, Thomas [1 ]
机构
[1] Lund Univ, Skane Univ Hosp, Dept Clin Sci Lund, Nephrol, Lund, Sweden
[2] Lund Univ, Skane Univ Hosp, Dept Lab Med Lund, Haematol & Transfus Med, Lund, Sweden
关键词
ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES; WEGENERS-GRANULOMATOSIS; TH17; CELLS; SYSTEMIC VASCULITIDES; CONSENSUS CONFERENCE; MEDIATED REJECTION; PERIPHERAL-BLOOD; REGULATORY CELLS; RENAL-ALLOGRAFTS; GLOMERULONEPHRITIS;
D O I
10.1155/2018/6984563
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
T cell-mediated immune responses are thought to play an important role in the pathogenesis of anti-neutrophil cytoplasmic antibody- (ANCA-) associated vasculitides (AAV). CD4(+) T cells can be divided into subsets depending on their expression of chemokine receptors. In this study, different CD4(+) T cell populations in patients with AAV were analysed and compared to healthy blood donors as well as therapy controls. 18 patients with active AAV, 46 in remission, 21 healthy controls (HBD), and 15 therapy controls (TC) were enrolled. CD4(+) T cells were divided into Th1, Th2, and Th17 cells and further subdivided into naive, central memory, effector memory, and effector cells. Regulatory T cells were also analysed. Concentrations of cytokines and chemokines produced by the respective CD4(+) T cell subset in plasma from 33 of the patients were measured by ELISA and compared to HBD. Clinical data were collected on all patients. CCL20 concentrations and percentages of Th17 cells (p = 0.019) were elevated in AAV patients compared to HBD. AAV patients had lower percentages of naive CD4(+) T cells (p = 0.0016) and a corresponding increase in proportion of effector memory CD4(+) T cells when comparing to HBD (p = 0.027). Therapy controls showed similar results as AAV patients. In this study, we found that CD4(+) T cell phenotype distribution is altered in AAV patients, in line with previously published work. However, no differences were found between AAV patients and TC, stressing the importance of treatment impact on this kind of studies.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Pathology of ANCA-associated vasculitis
    Ferrario, Franco
    Vanzati, Alice
    Pagni, Fabio
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2013, 17 (05) : 652 - 658
  • [42] A Case of ANCA-Associated Vasculitis
    Hogan, Jonathan J.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2019, 14 (05): : 754 - 756
  • [43] The Future of ANCA-associated Vasculitis
    Holle, Julia U.
    Wieczorek, Stefan
    Gross, Wolfgang L.
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2010, 36 (03) : 609 - +
  • [44] Pathophysiology of ANCA-associated Vasculitis
    Al-Hussain, Turki
    Hussein, Maged H.
    Conca, Walter
    Al Mana, Hadeel
    Akhtar, Mohammed
    ADVANCES IN ANATOMIC PATHOLOGY, 2017, 24 (04) : 226 - 234
  • [45] Bacterial DNA motifs trigger ANCA production in ANCA-associated vasculitis in remission
    Tadema, Henko
    Abdulahad, Wayel H.
    Lepse, Nikola
    Stegeman, Coen A.
    Kallenberg, Cees G. M.
    Heeringa, Peter
    RHEUMATOLOGY, 2011, 50 (04) : 689 - 696
  • [46] ANCA-associated vasculitis (AAV)
    Aries, P. M.
    Schneeweis, C.
    KARDIOLOGE, 2009, 3 (04): : 339 - 348
  • [47] Biomarkers in ANCA-Associated Vasculitis
    Lindsay Lally
    Robert F. Spiera
    Current Rheumatology Reports, 2013, 15
  • [48] Rituximab in ANCA-Associated Vasculitis
    Hassan, Romina I.
    Gaffo, Angelo L.
    CURRENT RHEUMATOLOGY REPORTS, 2017, 19 (02)
  • [49] Role of therapeutic plasmapheresis in ANCA-associated vasculitis
    Walters, Giles
    PEDIATRIC NEPHROLOGY, 2016, 31 (02) : 217 - 225
  • [50] Pathophysiology of ANCA-associated small vessel vasculitis
    Kallenberg C.G.M.
    Current Rheumatology Reports, 2010, 12 (6) : 399 - 405